Back to Research Home
HNGEHinge Health, Inc.
Information Technology · EDP Services · Mid
$111.52+1.45%
As of 23 Oct 2026Mkt cap $7.4B
Stage 13
AVOID
Fundamentals
17.1/75
Technical
5.3/15
Independent
22.4/90
GCAE viewFundamental /75 is below the Stage 13 acceptable-business floor
Price
- 1M
- +21.2%
- 3M
- +48.5%
- 6M
- +151.8%
- 1Y
- +128.2%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- —
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 21.0x
- FCF yield
- 4.8%
Quality
- ROIC
- —
- Operating margin
- -44.6%
- FCF margin
- 29.0%
- Current ratio
- 1.5x
Growth
- Revenue growth
- +50.6%Latest FY YoY
- Revenue CAGR
- +41.7%
- EPS CAGR
- —
- FCF CAGR
- —
Capital
- Share-count trend
- +104.8%3Y annualised
- Net cash
- $200M-1.2x OCF
Annual trend
- CAGR 2023–2025
- +41.7%
- Latest · 2025
- $1B
- YoY
- +50.6%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
Fundamental /75 is below the Stage 13 acceptable-business floor
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-02
More details & evidence
Production decision
- Stage 13
- AVOID
- Technical state
- extended
- Rotation
- headwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded